MEK1/2 inhibitor inhibits neointima formation by activating miR-126-3p/ C-X-C motif chemokine ligand 12 (CXCL12)/C-X-C motif chemokine receptor 4 (CXCR4) axis-Reference-Cited by-同舟云学术

MEK1/2 inhibitor inhibits neointima formation by activating miR-126-3p/ C-X-C motif chemokine ligand 12 (CXCL12)/C-X-C motif chemokine receptor 4 (CXCR4) axis

Published:2022-04-01 Issue:4 Volume:13 Page:11214-11227
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Yan Yali¹,Zhu Mengmeng¹,Ma Jialing¹,He Xiaoyu¹,Yang Xiaoxiao¹,Xu Hongmei¹,Jiang Meixiu²,Zhang Shuang¹,Duan Yajun¹,Han Jihong¹³,Chen Yuanli¹^ORCID

Affiliation:

1. Key Laboratory of Metabolism and Regulation for Major Diseases of Anhui Higher Education Institutes, School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui, China

2. The Institute of Translational Medicine, the National Engineering Research Center for Bioengineering Drugs and the Technologies, Nanchang University, Nanchang, Jiangxi, China

3. College of Life Sciences, Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Bioactive Materials of Ministry of Education, Nankai University, Tianjin, Hebei, China

Funder

China Postdoctoral Science Foundation Grants

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21655979.2022.2063496

Reference37 articles.

1. Vascular smooth muscle cells in atherosclerosis

2. A novel model of intimal hyperplasia with graded hypoosmotic damage

3. MicroRNAs: Target Recognition and Regulatory Functions

4. The Endothelial-Specific MicroRNA miR-126 Governs Vascular Integrity and Angiogenesis

5. MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical significance of lncRNA XIST expression in cholangiocarcinoma and its effect on cell migration and invasion;Clinics and Research in Hepatology and Gastroenterology;2024-08

2. Targeting VCAM-1: a therapeutic opportunity for vascular damage;Expert Opinion on Therapeutic Targets;2023-03-04